Rep. Cisneros Buys Tandem Diabetes Care Shares

The Democratic congressman from California disclosed a stock purchase in the medical device company.

Apr. 11, 2026 at 3:08am

Got story updates? Submit your updates here. ›

A photorealistic studio shot of a stack of sleek, metallic medical device components arranged on a plain white background, conveying the abstract corporate strategy and finance behind the medical technology industry.A conceptual still life highlighting the financial interests of a prominent elected official in a leading medical device company.San Diego Today

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought between $1,001 and $15,000 worth of shares in Tandem Diabetes Care, Inc. (NASDAQ:TNDM), according to a filing disclosed on April 7th. The trade occurred in the Representative's '150 MAIN STREET TRUST > BANK OF AMERICA' account.

Why it matters

As a member of Congress, Cisneros' stock trades are subject to public disclosure and scrutiny. This purchase of Tandem Diabetes shares could signal the Representative's confidence in the medical device company's future performance.

The details

Tandem Diabetes Care, Inc. is a San Diego-based company that designs and commercializes insulin delivery systems for people with diabetes. The company's flagship product is the t:slim X2 Insulin Pump, which features automated insulin delivery algorithms and integration with continuous glucose monitoring (CGM) sensors.

  • Cisneros disclosed the stock purchase on April 7, 2026.
  • The trade occurred on March 3, 2026.

The players

Representative Gilbert Ray Cisneros, Jr.

A Democratic member of the U.S. House of Representatives from California's 31st Congressional District. Cisneros is running for re-election in 2026.

Tandem Diabetes Care, Inc.

A medical device company focused on the design, development and commercialization of innovative insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in San Diego, California.

Got photos? Submit your photos here. ›

What’s next

Cisneros' stock purchase will likely be scrutinized by watchdog groups and the media, as members of Congress are required to disclose their trades to ensure transparency.

The takeaway

This transaction highlights the financial interests of a prominent elected official and the potential influence that could come with stock ownership in a medical device company, raising questions about conflicts of interest and the role of money in politics.